Nadia Waheed

Insider Reports History

Location
Bedford, MA
Signature
/s/ Todd Anderman, Attorney-in-Fact for Nadia Waheed
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nadia Waheed:

Company Role Class Num Shares Value Price $ Report Date Ownership
OCULAR THERAPEUTIX, INC Chief Medical Officer Common Stock 314,907 $2,437,380 $7.74 20 Feb 2026 Direct
OCULAR THERAPEUTIX, INC Chief Medical Officer Stock Option (Right to Buy) 240,932 02 Jan 2026 Direct

Insider Reports Filed by Nadia Waheed

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OCUL OCULAR THERAPEUTIX, INC 20 Feb 2026 1 -$27,167 4 Chief Medical Officer 24 Feb 2026, 18:13
OCUL OCULAR THERAPEUTIX, INC 12 Feb 2026 1 -$71,082 4 Chief Medical Officer 17 Feb 2026, 20:28
OCUL OCULAR THERAPEUTIX, INC 02 Jan 2026 2 $0 4 Chief Medical Officer 06 Jan 2026, 16:04
OCUL OCULAR THERAPEUTIX, INC 12 Aug 2025 2 $0 4 Chief Medical Officer 14 Aug 2025, 17:51
OCUL OCULAR THERAPEUTIX, INC 02 Jun 2025 1 -$111,581 4 Chief Medical Officer 03 Jun 2025, 16:20
OCUL OCULAR THERAPEUTIX, INC 11 Feb 2025 2 $0 4 Chief Medical Officer 13 Feb 2025, 20:37
OCUL OCULAR THERAPEUTIX, INC 01 Jun 2024 2 $0 4 Chief Medical Officer 04 Jun 2024, 17:28
OCUL OCULAR THERAPEUTIX, INC 01 Jun 2024 0 $0 3 Chief Medical Officer 04 Jun 2024, 17:26